Skip to main content
Fig. 2 | Advances in Rheumatology

Fig. 2

From: COVID-19 on patients with immune-mediated rheumatic disease: a comparative study of disease activity, fatigue, and psychological distress over six months

Fig. 2

Comparison of disease activity scores across the three study visits in patients with systemic lupus erythematosus (SLEDAI) (A) and rheumatoid arthritis (CDAI) (B) who self-reported clinical worsening after COVID-19. Visit 1 (inclusion); V2: visit 2; V3: visit 3. CDAI: Clinical Disease Activity Score; SLEDAI: Systemic Lupus Erythematosus Disease Activity Index. One-way ANOVA (95% CI), repeated measures, multiple comparison of the mean of each column with the mean of every other column

Back to article page

Advances in Rheumatology

ISSN: 2523-3106